Latest Posts

  • The Control-IQ artificial pancreas system was derived from research done at the Center for Diabetes Technology here at UVA. Image credit: Tandem Diabetes Care

    The Artificial Pancreas Is Up for Final Approval From the FDA

    The artificial pancreas pioneered here at UVA is more effective than existing treatments at controlling blood sugar in people with type 1 diabetes, a new study in the prestigious New England Journal of Medicine has found.

  • Transplant surgeon Kenneth Brayman believes he and his colleagues have identified a way to prevent type 1 diabetes, and to benefit people who already have it.

    A Potential Way to Prevent Type 1 Diabetes

    Our Kenneth Brayman, MD, and his colleagues are hot on the trail of what they believe could be a way to prevent type 1 diabetes. The solution, they think, could be a concentrated form of a naturally occuring antibody called human immunoglobulin, or IgM.

  • A promising cancer drug is being developed based on a discovery by Kimberly Kelly, PhD.

    Big Backing for a Promising Cancer Drug

    A promising cancer drug that’s being developed based on a discovery by our Kimberly Kelly, PhD, is attracting major interest — to the tune of $25 million.

  • David Kashatus, PhD, has given us important new insights into pancreatic cancer and how the aggressive cancer fuels its growth.

    Pancreatic Cancer: Years of Work Pay Off

    When our David Kashatus, PhD, was first interviewing here in 2012, he laid out an ambitious research project that would help us better understand pancreatic cancer. Seven years later, he has completed that work and given us important new insights into how the aggressive cancer fuels its growth.